apyrase and Leukemia--Myeloid--Acute

apyrase has been researched along with Leukemia--Myeloid--Acute* in 3 studies

Other Studies

3 other study(ies) available for apyrase and Leukemia--Myeloid--Acute

ArticleYear
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
    International journal of molecular sciences, 2021, Nov-29, Volume: 22, Issue:23

    Topics: Adult; Aged; Aged, 80 and over; Apyrase; Case-Control Studies; Humans; Immunotherapy; Killer Cells, Natural; Leukemia, Myeloid, Acute; Middle Aged; Receptor, Adenosine A2A; Receptors, Immunologic; Young Adult

2021
Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.
    Cancer discovery, 2020, Volume: 10, Issue:10

    Relapses driven by chemoresistant leukemic cell populations are the main cause of mortality for patients with acute myeloid leukemia (AML). Here, we show that the ectonucleotidase CD39 (ENTPD1) is upregulated in cytarabine-resistant leukemic cells from both AML cell lines and patient samples

    Topics: Antigens, CD; Apyrase; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitochondria

2020
Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis.
    British journal of haematology, 2014, Volume: 165, Issue:5

    Topics: Antigens, CD; Apyrase; Humans; Immune Tolerance; Immunophenotyping; Leukemia, Myeloid, Acute; Tumor Microenvironment

2014